All news

Data management tech aims to double COVID-19 testing capacity

24-Mar-2020 By Jenni Spinner

Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide.

Generics manufacturer prioritizes cardiac drugs amid shortages fears

23-Mar-2020 By Vassia Barba

Medivant to prioritize manufacturing of four generic drugs for cardiac diseases, amid fears of drug shortages due to COVID-19.

EMA calls to scale up COVID-19 trials for conclusive data

23-Mar-2020 By Vassia Barba

The agency says the industry should prioritize large randomized controlled studies developing COVID-19 treatments, to acquire robust data.

Trial management service available for free amid COVID-19 pandemic

23-Mar-2020 By Vassia Barba

Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.

TrialJectory matches cancer patients, clinical trials

23-Mar-2020 By Jenni Spinner

The AI-assisted platform, created by a cancer survivor, connects oncology patients with care options in an online marketplace.

Industry ups chloroquine production, donates millions of doses

23-Mar-2020 By Ben Hargreaves

Manufacturers of hydroxychloroquine are increasing production and a number have offered to donate doses to combat COVID-19.

Eli Lilly shifts clinical trial activity during coronavirus

23-Mar-2020 By Jenni Spinner

The pharmaceutical company has announced several changes to its clinical trial activities in the face of the global pandemic.

Demand for remote clinical management explodes due to coronavirus

19-Mar-2020 By Vassia Barba

CluePoints sees demand on services supporting remote clinical trials management ‘dramatically’ increase amid the ongoing coronavirus pandemic.

FDA issues coronavirus guidance for clinical trials

19-Mar-2020 By Jenni Spinner

The document offers pointers for the industry, investigators and institutional review boards operating trials in the face of the coronavirus pandemic.

Oracle Health launches decentralized trial survey

19-Mar-2020 By Jenni Spinner

The company is seeking industry insights on the use of remote studies and decentralized clinical trial technology.

ViiV Healthcare, UNC extend HIV partnership

19-Mar-2020 By Jenni Spinner

Funding has been extended for the public-private collaboration, which unites academic and pharma researchers on discovering HIV treatments.

FDA halts domestic inspections, calls for industry to ‘own’ quality

19-Mar-2020 By Ben Hargreaves

The US FDA announces that it will no longer be able to carry out domestic facility inspections due to the risk posed by COVID-19.

FDA approves migraine drug formulated for fast dispersion

19-Mar-2020 By Vassia Barba

Biohaven’s drug for acute treatment of migraine, manufactured using Catalent’s Zydis technology for orally disintegrating tablets, receives approval from the US FDA.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

Fujifilm Diosynth to create biocampus in the UK

18-Mar-2020 By Vassia Barba

Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development.